Bioengineered organs are no longer just structural substitutes. A review published in Trends in Biotechnology introduces a groundbreaking concept: biohybrid-engineered tissue (BHET) platforms—living constructs integrated with electronics that can monitor, modulate, and even autonomously control their own functions.